Evidence map›Paper›PMID 35831331›Full record

ArticleScientific reports2022

Biometric and refractive changes following the monocular application of peripheral myopic defocus using a novel augmented-reality optical system in adults.

Ryo Kubota, Nabin R Joshi, Tara J Fitzgerald, Inna Samandarova, Maksud Oliva, Arkady Selenow, Amitava Gupta, Steven Ali, G Lynn Mitchell, Robert Chun and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ryo KubotaKubota Vision Inc., Seattle, WA, USA. dr.kubota@kubotavision.com.
Nabin R JoshiManhattan Vision Associates - Institute for Vision Research, New York, NY, USA.
Tara J FitzgeraldManhattan Vision Associates - Institute for Vision Research, New York, NY, USA.
Inna SamandarovaManhattan Vision Associates - Institute for Vision Research, New York, NY, USA.
Maksud OlivaManhattan Vision Associates - Institute for Vision Research, New York, NY, USA.
Arkady SelenowManhattan Vision Associates - Institute for Vision Research, New York, NY, USA.
Amitava GuptaKubota Vision Inc., Seattle, WA, USA.
Steven AliManhattan Vision Associates - Institute for Vision Research, New York, NY, USA.
G Lynn MitchellThe Ohio State University College of Optometry, Columbus, OH, USA.
Robert ChunManhattan Vision Associates - Institute for Vision Research, New York, NY, USA.
Kenneth J CiuffredaState University of New York (SUNY) College of Optometry, New York, NY, USA.
Manhattan Institute for Policy Research · USSUNY College of Optometry · USThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of myopia is growing at an alarming rate and is associated with axial elongation of the eye. The cause of this undesirable physiological change involves multiple factors. When the magnitude of myopia approaches high levels, this accompanying mechanical effect increases the risk of developing other clinical conditions associated with permanent vision loss. Prior work has investigated how we may halt or reverse this process of axial elongation associated with myopic progression when we expose the eye to a peripheral myopic defocus stimulus. Specifically, the known, short-term response to myopic defocus stimulation is promising and demonstrates the possibility of establishing more permanent effects by regulating the axial length of the eye with specific defocus stimulation. However, how to directly convert these known, short-term effects into more long-term, permanent changes to effectively prevent these unfavourable physiological and refractive changes over time is yet to be understood. Here, we show for the first time that we can produce sustained, long-term reductions in axial length and refractive endpoints with cumulative short-term exposure to specific myopic defocus stimuli using a novel optical design that incorporates an augmented reality optical system. We believe that this technology will have the potential to improve the quality of vision in mankind.

Indexed as

Augmented RealityMyopiaOptical DevicesAdultAxial Length, EyeBiometryChoroidHumansRefraction, Ocular

Identifiers

PMID35831331
PMCPMC9279468
OpenAlexW4285393246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.